Treatment of Herpetic Whitlow
The recommended first-line treatment for herpetic whitlow is oral antiviral therapy with acyclovir 200 mg five times daily for 7-10 days, valacyclovir 500 mg twice daily, or famciclovir 250 mg twice daily. 1
Clinical Presentation and Diagnosis
Herpetic whitlow is a herpes simplex virus infection of the digits characterized by:
- Initial symptoms: pain, tingling, and burning of the distal phalanx 2
- Progression to swelling and vesicles on an erythematous base 2
- Self-limiting infection typically resolving in about three weeks 2
Diagnosis can be made clinically and confirmed by:
- Tzanck test
- Viral culture
- HSV antibody titers
- Fluorescent antibody tests 3
Treatment Algorithm
First-Line Treatment Options
Oral Antivirals (Preferred):
For Severe Cases:
- Intravenous acyclovir 5-10 mg/kg body weight every 8 hours for 5-7 days or until clinical resolution 1
Management Based on Infection Type
Primary Infection:
Recurrent Infection:
Suppressive Therapy Options
For patients with frequent recurrences:
- Valacyclovir 500 mg orally twice daily (preferred in HIV-infected persons) 1
- Acyclovir 400 mg orally twice daily 1
- Famciclovir 250 mg orally twice daily 1
Special Considerations
Immunocompromised Patients
- May require longer duration of therapy or higher doses
- Valacyclovir is often preferred due to its efficacy and safety profile 1
- For acyclovir-resistant HSV, consider foscarnet rather than ganciclovir 1
Renal Impairment
Dosage adjustments required based on creatinine clearance:
- CrCl 10-29 mL/min: Valacyclovir 500 mg every 24 hours 1
- CrCl <10 mL/min: Valacyclovir 500 mg every 24 hours 1
Important Caveats
Avoid Surgical Intervention:
Diagnostic Challenges:
Prevention Measures for Healthcare Workers:
Patient Education:
Early recognition and prompt antiviral therapy are key to managing herpetic whitlow effectively and preventing complications or unnecessary surgical interventions.